Abstract
Sugammadex, a new reversal agent for rocuronium, encapsulates the rocuronium molecule and results in rapid reversal of rocuronium-induced neuromuscular blockade. A case in which sugammadex was used to treat an anaphylactic reaction that occurred after rocuronium is presented. The binding/encapsulation of rocuronium by sugammadex may selectively eliminate the antigenic quaternary ammonium activity of circulating rocuronium, and prevent the propagation of rocuronium-induced anaphylaxis.
| Original language | English |
|---|---|
| Pages (from-to) | 62-64 |
| Number of pages | 3 |
| Journal | Journal of Clinical Anesthesia |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 02-2012 |
All Science Journal Classification (ASJC) codes
- Anesthesiology and Pain Medicine
Fingerprint
Dive into the research topics of 'Successful management of rocuronium-induced anaphylactic reactions with sugammadex: A case report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver